Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Study on the use of carboxymethyl chitosan grafted with pyroglutamic acid for photodamage repair.

Created on 06 Oct 2026

Authors

Ruibao Ju, Xin Wang, Ju Peng, Lixin Xia, Zhiwen Jiang, Jinhua Chi, Shuo Wang, Baoqin Han

Published in

International journal of biological macromolecules. Pages 154740. Oct 05, 2026. Epub Oct 05, 2026.

Abstract

To develop high-efficiency materials for skin photodamage repair, in this study, carboxymethyl chitosan-pyroglutamic acid (CMCS-Pyr) was synthesized by grafting pyroglutamic acid onto carboxymethyl chitosan (CMCS) via an amide reaction, achieving a grafting rate of 19.28%. Rheological analysis identified 10% as the optimal application concentration of CMCS-Pyr. In vitro experiments demonstrated that the material had a hemolysis rate of less than 5% and no skin irritation. It exhibits multiple free radical scavenging capacities, with ABTS, DPPH and ·OH radical scavenging rates of 52.8%, 50.9% and 90.5%, respectively. CMCS-Pyr could significantly enhance the superoxide dismutase (SOD) activity of HaCaT cells, and promote cell migration as well as collagen synthesis. In animal experiments based on the mouse UVB-induced skin photodamage model, CMCS-Pyr remarkably increased the water content and maximum tensile strength of damaged skin, inhibited the expressions of matrix metalloproteinase-9 (MMP-9) and nuclear factor-kappa B p65 (NF-κB-p65), and reduced the malondialdehyde (MDA) content. Transcriptome and quantitative real-time polymerase chain reaction (qPCR) analyses confirmed that CMCS-Pyr up-regulated the expressions of genes such as COL1 and COL3 and down-regulated inflammatory factors by regulating the MAPK/NF-κB signaling pathway, thereby exerting a synergistic effect of anti-inflammation, anti-oxidation and pro-repair. Collectively, CMCS-Pyr is a promising material for skin photodamage repair.

PMID:
42833328
Bibliographic data and abstract were imported from PubMed on 06 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement